IPF-Acute Exacerbations: Advances and Future Perspectives
- PMID: 35496286
- PMCID: PMC9047939
- DOI: 10.3389/fphar.2022.836553
IPF-Acute Exacerbations: Advances and Future Perspectives
Keywords: acute exacerbations; acute respiratory distress syndrome; idiopathic pulmonary fibrosis; immunosuppressants; infections; microbiome; steroids.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Bellani G., Laffey J. G., Pham T., Fan E., Brochard L., Esteban A., et al. (2016). LUNG SAFE Investigators; ESICM Trials GroupEpidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 315, 788–800. 10.1001/jama.2016.0291 - DOI - PubMed
LinkOut - more resources
Full Text Sources
